Safety and efficacy of burosumab in improving phosphate metabolism, bone health, and quality of life in adolescents with X-linked hypophosphatemic rickets
-
Published:2024-08
Issue:
Volume:70
Page:104958
-
ISSN:1769-7212
-
Container-title:European Journal of Medical Genetics
-
language:en
-
Short-container-title:European Journal of Medical Genetics
Author:
Baroncelli Giampiero I.ORCID,
Grandone Anna,
Aversa Antonio,
Sessa Maria Rita,
Pelosini Caterina,
Michelucci Angela,
Toschi Benedetta,
Manca Mario,
Isola Alessandro,
Comberiati Pasquale
Reference32 articles.
1. X-linked hypophosphatemic rickets: multisystemic disorder in children requiring multidisciplinary management;Baroncelli;Front. Endocrinol.,2021
2. Pulp chamber features, prevalence of abscesses, disease severity, and phex mutation in X-linked hypophosphatemic rickets;Baroncelli;J. Bone Miner. Metabol.,2021
3. Intact FGF23 concentration in healthy infants, children, and adolescents, and diagnostic usefulness in patients with X‐linked hypophosphatemic rickets;Baroncelli;J. Endocxrinol. Invest.,2024
4. Incidence and prevalence of nutritional and hereditary rickets in Southern Denmark;Beck-Nielsen;Eur. J. Endocrinol.,2009
5. FGF23 and its role in X-linked hypophosphatemia-related morbidity;Beck-Nielsen;Orphanet J. Rare Dis.,2019